Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: Jul 30, 2019

Total Value: $2.397B (100.0% shares, 0.0% debt)

Holdings (37)

BMRN BIOMARIN PHARMACEUTICAL INC 9.8%
Value $235M Shares 2,641,485 Est. Cost $80.19 Unrealized +15.6%
INSM INSMED INC 9.3%
Value $222M Shares 7,653,617 Est. Cost $16.83 Unrealized +54.0%
ABIOMED INC 8.3%
Value $200M Shares 698,654 Est. Cost $35.35 Unrealized
UTHR UNITED THERAPEUTICS CORP DEL 8.0%
Value $192M Shares 1,632,025 Est. Cost $88.73 Unrealized +31.3%
ALEXION PHARMACEUTICALS INC 6.9%
Value $166M Shares 1,229,030 Est. Cost $121.54 Unrealized
STAA STAAR SURGICAL CO 6.0%
Value $144M Shares 4,218,902 Est. Cost $13.06 Unrealized +170.9%
SAGE THERAPEUTICS INC 5.7%
Value $136M Shares 857,681 Est. Cost $48.62 Unrealized
CLOVIS ONCOLOGY INC 5.4%
Value $130M Shares 5,239,304 Est. Cost $51.30 Unrealized
IMMUNOMEDICS INC 5.1%
Value $123M Shares 6,381,555 Est. Cost $13.36 Unrealized
FOLD AMICUS THERAPEUTICS INC 4.3%
Value $104M Shares 7,619,833 Est. Cost $7.42 Unrealized +64.6%
VNDA VANDA PHARMACEUTICALS INC 3.9%
Value $93.01M Shares 5,055,050 Est. Cost $11.21 Unrealized +103.3%
WRIGHT MED GROUP N V 3.6%
Value $87.16M Shares 2,771,394 Est. Cost $23.42 Unrealized
EPIZYME INC 3.6%
Value $85.93M Shares 6,935,074 Est. Cost $15.12 Unrealized
AIMMUNE THERAPEUTICS INC 3.5%
Value $83.79M Shares 3,748,939 Est. Cost $22.88 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 2.5%
Value $60.37M Shares 2,248,403 Est. Cost $27.39 Unrealized -14.7%
ALGN ALIGN TECHNOLOGY INC 2.0%
Value $47.03M Shares 165,405 Est. Cost $114.31 Unrealized +108.8%
PBYI PUMA BIOTECHNOLOGY INC 1.9%
Value $45.8M Shares 1,180,780 Est. Cost $30.02 Unrealized +1.7%
AMAG PHARMACEUTICALS INC 1.8%
Value $44.07M Shares 3,421,306 Est. Cost $29.07 Unrealized
KARYOPHARM THERAPEUTICS INC 1.3%
Value $30.73M Shares 5,262,263 Est. Cost $17.42 Unrealized
EXAS EXACT SCIENCES CORP 1.1%
Value $27.28M Shares 314,889 Est. Cost $13.61 Unrealized +525.3%
MOMENTA PHARMACEUTICALS INC 1.1%
Value $26.76M Shares 1,841,613 Est. Cost $14.12 Unrealized
ALDER BIOPHARMACEUTICALS INC 1.1%
Value $25.41M Shares 1,861,630 Est. Cost $11.48 Unrealized
CELGENE CORP 1.0%
Value $25.13M Shares 266,333 Est. Cost $89.02 Unrealized
PRTA PROTHENA CORP PLC 0.6%
Value $13.45M Shares 1,108,510 Est. Cost $32.98 Unrealized -62.1%
KLDO KALEIDO BIOSCIENCES INC 0.5%
Value $12.57M Shares 866,666 Est. Cost $13.76 Unrealized 0.0%
GILD GILEAD SCIENCES INC 0.5%
Value $11.44M Shares 175,900 Est. Cost $62.02 Unrealized -18.0%
RIGEL PHARMACEUTICALS INC 0.4%
Value $10.24M Shares 3,985,945 Est. Cost $3.40 Unrealized
DICERNA PHARMACEUTICALS INC 0.3%
Value $7.338M Shares 500,913 Est. Cost $5.39 Unrealized
ALIMERA SCIENCES INC 0.1%
Value $3.195M Shares 3,013,793 Est. Cost $4.88 Unrealized
ZOGENIX INC 0.1%
Value $1.623M Shares 29,500 Est. Cost $13.36 Unrealized
SUNESIS PHARMACEUTICALS INC 0.1%
Value $1.412M Shares 1,162,473 Est. Cost $4.37 Unrealized
CYTK CYTOKINETICS INC 0.0%
Value $1.001M Shares 123,686 Est. Cost $6.71 Unrealized +9.5%
MARINUS PHARMACEUTICALS INC 0.0%
Value $477K Shares 114,221 Est. Cost $4.18 Unrealized
SOPHIRIS BIO INC 0.0%
Value $245K Shares 247,000 Est. Cost $2.60 Unrealized
IDERA PHARMACEUTICALS INC 0.0%
Value $196K Shares 77,044 Est. Cost $8.90 Unrealized
MELINTA THERAPEUTICS INC 0.0%
Value $36,000 Shares 10,137 Est. Cost $3.55 Unrealized
HISTOGENICS CORP 0.0%
Value $35,000 Shares 302,922 Est. Cost $11.00 Unrealized